Suppressive efficacy and proliferative capacity of human regulatory T cells in allogeneic and xenogeneic responses

Transplantation. 2008 Nov 27;86(10):1452-62. doi: 10.1097/TP.0b013e318188acb0.

Abstract

Background: An understanding of the mechanisms that suppress the human anti-pig cellular response is key for xenotransplantation. We have compared the ability of human regulatory T cells (Tregs) to suppress xenogeneic and allogeneic responses in vitro.

Methods: Human peripheral blood mononuclear cells (PBMC), CD4+ T cells, or CD4+ CD25- T cells were stimulated with irradiated human or wild type (WT) or alpha1,3-galactosyltransferase gene-knockout (GT-KO) pig PBMC in the presence or absence of human CD4+ CD25 high Tregs. In separate experiments, 5- (and 6)-carboxyfluorescein diacetate succinimidyl ester-labeled human CD4+ T cells were stimulated with human or pig PBMC. The expansion and precursor frequencies of allo- and xenoreactive Tregs were assessed by labeling with FoxP3 mAb and flow cytometric analysis.

Results: The responses of human PBMC, CD4+ T cells, and CD4+ CD25- T cells to pig PBMC were stronger than to human PBMC (P<0.05). Human anti-GT-KO responses were weaker than anti-WT responses (P<0.05). Human CD4+ CD25 high Tregs suppressed proliferation of CD4+ CD25- T cells to both human and pig PBMC stimulator cells with the same efficiency. Alloreactive CD4+ CD25+ FoxP3 high responder T cells proliferated more than their xenoreactive counterparts (P<0.05), although xenoreactive CD4+ CD25+ T cells proliferated more than alloreactive cells (P<0.05). There was no difference in precursor frequency between allo- and xeno-reactive CD4+ CD25+ FoxP3 high cells.

Conclusions: Human T-cell responses to pig cells are stronger than to allogeneic cells. The human response to GT-KO PBMC is weaker than to WT PBMC. Although human Tregs can suppress both responses, expansion of CD4+ CD25+ FoxP3 high cells against pig PBMC is weaker than against human PBMC. More human Tregs may be required to suppress the stronger xenogeneic response.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Genetically Modified
  • Antigens, CD / immunology
  • CD4-Positive T-Lymphocytes / immunology
  • Galactosyltransferases / deficiency
  • Galactosyltransferases / genetics
  • Graft Rejection / genetics
  • Graft Rejection / immunology
  • Humans
  • Immunosuppression Therapy / methods
  • Interleukin-2 Receptor alpha Subunit / immunology
  • Swine / genetics
  • Swine / immunology
  • T-Lymphocytes, Regulatory / immunology*
  • Transplantation, Heterologous / immunology*
  • Transplantation, Homologous / immunology*

Substances

  • Antigens, CD
  • Interleukin-2 Receptor alpha Subunit
  • Galactosyltransferases